A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor and Collaborators
University of Pittsburgh
National Cancer Institute (NCI)
Contact
Athanassios Argiris, MD
(412) 623-4083
argirisae@upmc.edu
Rita Johnson, RN
(412) 547-5871
johnsonr1@upmc.edu
United States, Michigan
University of Michigan Recruiting
Ann Arbor, Michigan, United States, 48109-0848
Principal Investigator: Francis P Worden, MD
United States, Ohio
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Principal Investigator: Panayiotis Savvides, MD, PhD, MPH
United States, Pennsylvania
UPMC / UPMC Cancer Centers Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Jamie Haggerty
Principal Investigator: Athanassios Argiris, MD
United States, Texas
University of Texas MD Anderson Recruiting
Houston, Texas, United States, 77030
Principal Investigator: Merrill s Kies, MD
Principal Investigator
Athanassios Argiris, MD
ECOG
Clinical Trials.gov Identifier
NCT00409565
